— Know what they know.
Not Investment Advice

ICLR NASDAQ

ICON Public Limited Company
1W: -6.0% 1M: +1.4% 3M: -5.2% YTD: -14.1% 1Y: -15.7% 3Y: -34.7% 5Y: -42.8%
$162.05
+0.20 (+0.12%)
 
Weekly Expected Move ±6.3%
$142 $152 $162 $172 $182
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 49 · $12.4B mcap · 76M float · 1.25% daily turnover · Short 61% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$8.3B +2.0% ▲
5Y CAGR: +24.2%
Gross Profit
$2.4B +1.5% ▲
5Y CAGR: +24.0%
Operating Income
$1.1B +14.8% ▲
5Y CAGR: +20.4%
Net Income
$791M +29.3% ▲
5Y CAGR: +16.2%
EPS (Diluted)
$9.53 +28.8% ▲
5Y CAGR: +7.0%
EBITDA
$1.6B +2.8% ▲
5Y CAGR: +24.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$2.8B$5.5B$7.7B$8.1B$8.3B
YoY Growth-0.3%+95.9%+41.2%+4.9%+2.0%
Cost of Revenue$2.0B$4.0B$5.5B$5.7B$5.8B
Gross Profit$808M$1.5B$2.2B$2.4B$2.4B
Gross Margin28.9%27.5%28.6%29.6%29.4%
R&D Expenses$0$0$0$0$0
SG&A Expenses$342M$585M$779M$776M$728M
Operating Expenses$416M$1.1B$1.4B$1.4B$1.3B
Operating Income$392M$379M$795M$956M$1.1B
Operating Margin14.0%6.9%10.3%11.8%13.3%
Interest Expense$13M$182M$230M$337M$237M
Income Before Tax$381M$195M$565M$624M$869M
Tax Expense$48M$41M$59M$12M$78M
Net Income$328M$153M$505M$612M$791M
Net Margin11.7%2.8%6.5%7.5%9.6%
EPS (Diluted)$6.24$2.25$6.13$7.40$9.53
EBITDA$489M$739M$1.4B$1.5B$1.6B
Shares Outstanding53M68M82M83M83M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms